154 related articles for article (PubMed ID: 29725969)
1. Differences in Glycemic Control in Diabetic and Non-diabetic Patients with Parenteral Nutrition Using a Basal plus Correction Insulin Regimen: An Observational, Retrospective Study.
Ramos A; Rabasa F; Mendoza L; Cardenete J; Gill P; Morilla A; Cardona D; Pérez A
Diabetes Ther; 2018 Jun; 9(3):1359-1367. PubMed ID: 29725969
[TBL] [Abstract][Full Text] [Related]
2. Glargine Insulin Use Versus Continuous Regular Insulin in Diabetic Surgical Noncritically Ill Patients Receiving Parenteral Nutrition: Randomized Controlled Study.
Hakeam HA; Mulia HA; Azzam A; Amin T
JPEN J Parenter Enteral Nutr; 2017 Sep; 41(7):1110-1118. PubMed ID: 27091835
[TBL] [Abstract][Full Text] [Related]
3. Reliability of Inpatient CGM: Comparison to Standard of Care.
Price C; Ditton G; Russell GB; Aloi J
J Diabetes Sci Technol; 2023 Mar; 17(2):329-335. PubMed ID: 34911384
[TBL] [Abstract][Full Text] [Related]
4. Glycemic Control in Adult Surgical Patients Receiving Regular Insulin Added to Parenteral Nutrition vs Insulin Glargine: A Retrospective Chart Review.
Truong S; Park A; Kamalay S; Hung N; Meyer JG; Nguyen N; Momenzadeh A
Nutr Clin Pract; 2019 Oct; 34(5):775-782. PubMed ID: 30693980
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of regular versus glargine insulin in stable critical care patients receiving parenteral nutrition: a randomized controlled trial.
Oghazian MB; Javadi MR; Radfar M; Torkamandi H; Sadeghi M; Hayatshahi A; Gholami K
Pharmacotherapy; 2015 Feb; 35(2):148-57. PubMed ID: 25689245
[TBL] [Abstract][Full Text] [Related]
6. Hyperglycemia is associated with poor outcomes in surgical critically ill patients receiving parenteral nutrition.
Yan CL; Huang YB; Chen CY; Huang GS; Yeh MK; Liaw WJ
Acta Anaesthesiol Taiwan; 2013 Jun; 51(2):67-72. PubMed ID: 23968657
[TBL] [Abstract][Full Text] [Related]
7. Hyperglycemia is associated with increased hospital complications and mortality during parenteral nutrition.
Pasquel FJ; Smiley D; Spiegelman R; Lin E; Peng L; Umpierrez GE
Hosp Pract (1995); 2011 Apr; 39(2):81-8. PubMed ID: 21576900
[TBL] [Abstract][Full Text] [Related]
8. Retrospective Evaluation of Glycemic Control With Basal-Bolus or Neutral Protamine Hagedorn Insulin Regimens in Patients Receiving Continuous Enteral Nutrition Therapy in Medicine Wards.
Hijaze D; Szalat A
Nutr Clin Pract; 2017 Aug; 32(4):557-562. PubMed ID: 28760108
[TBL] [Abstract][Full Text] [Related]
9. Predictors of insulin requirements among hospitalized adults receiving parenteral nutrition.
Roehl KA; Lach K; Coltman AE; Bacon CA; Singh S; Peterson SJ; Sowa DC
JPEN J Parenter Enteral Nutr; 2013 Nov; 37(6):755-62. PubMed ID: 23770842
[TBL] [Abstract][Full Text] [Related]
10. Differences in inpatient glycemic control and response to subcutaneous insulin therapy between medicine and surgery patients with type 2 diabetes.
Smiley D; Umpierrez GE; Hermayer K; Newton C; Jacobs S; Olson DE; Khan A; Rizzo M; Peng L; Reyes D; Cardona S; Fonseca V
J Diabetes Complications; 2013; 27(6):637-41. PubMed ID: 23911535
[TBL] [Abstract][Full Text] [Related]
11. Regular insulin added to total parenteral nutrition vs subcutaneous glargine in non-critically ill diabetic inpatients, a multicenter randomized clinical trial: INSUPAR trial.
Olveira G; Abuín J; López R; Herranz S; García-Almeida JM; García-Malpartida K; Ferrer M; Cancer E; Luengo-Pérez LM; Álvarez J; Aragón C; Ocón MJ; García-Manzanares Á; Bretón I; Serrano-Aguayo P; Pérez-Ferre N; López-Gómez JJ; Olivares J; Arraiza C; Tejera C; Martín JD; García S; Abad ÁL; Alhambra MR; Zugasti A; Parra J; Torrejón S; Tapia MJ
Clin Nutr; 2020 Feb; 39(2):388-394. PubMed ID: 30930133
[TBL] [Abstract][Full Text] [Related]
12. Glucose variability is an independent predictor of mortality in hospitalized patients treated with total parenteral nutrition.
Farrokhi F; Chandra P; Smiley D; Pasquel FJ; Peng L; Newton CA; Umpierrez GE
Endocr Pract; 2014 Jan; 20(1):41-5. PubMed ID: 24013986
[TBL] [Abstract][Full Text] [Related]
13. Insulin requirements in non-critically ill hospitalized patients with diabetes and steroid-induced hyperglycemia.
Spanakis EK; Shah N; Malhotra K; Kemmerer T; Yeh HC; Golden SH
Hosp Pract (1995); 2014 Apr; 42(2):23-30. PubMed ID: 24769781
[TBL] [Abstract][Full Text] [Related]
14. Randomized study comparing a Basal-bolus with a basal plus correction insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes: basal plus trial.
Umpierrez GE; Smiley D; Hermayer K; Khan A; Olson DE; Newton C; Jacobs S; Rizzo M; Peng L; Reyes D; Pinzon I; Fereira ME; Hunt V; Gore A; Toyoshima MT; Fonseca VA
Diabetes Care; 2013 Aug; 36(8):2169-74. PubMed ID: 23435159
[TBL] [Abstract][Full Text] [Related]
15. Impact of Insulin Degludec in Hospitalized Patients With and Without Type 2 Diabetes Requiring Parenteral/Enteral Nutrition: An Observational Study.
Fatati G; Di Donato A; Grandone I; Menicocci P; Mirri E; Prosperini G; Scardapane M; Rossi MC; Palazzi M
Adv Ther; 2018 Jun; 35(6):809-816. PubMed ID: 29777522
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Glycemic Variability and Hypoglycemic Events in Hospitalized Older Adults Treated with Basal Insulin plus Vildagliptin and Basal-Bolus Insulin Regimen: A Prospective Randomized Study.
Batule S; Ramos A; Pérez-Montes de Oca A; Fuentes N; Martínez S; Raga J; Pena X; Tural C; Muñoz P; Soldevila B; Alonso N; Umpierrez G; Puig-Domingo M
J Clin Med; 2022 May; 11(10):. PubMed ID: 35628938
[TBL] [Abstract][Full Text] [Related]
17. THE MANAGEMENT OF HYPERGLYCEMIA IN NONCRITICALLY ILL HOSPITALIZED PATIENTS TREATED WITH CONTINUOUS ENTERAL OR PARENTERAL NUTRITION.
Vennard KC; Selen DJ; Gilbert MP
Endocr Pract; 2018 Oct; 24(10):900-906. PubMed ID: 30035626
[TBL] [Abstract][Full Text] [Related]
18. Management of tight intraoperative glycemic control during off-pump coronary artery bypass surgery in diabetic and nondiabetic patients.
Lecomte P; Foubert L; Coddens J; Dewulf B; Nobels F; Casselman F; Cammu G
J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):937-42. PubMed ID: 21640613
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Dipeptidyl Peptidase-IV Inhibitor Use in Hospitalized Patients With Diabetes.
Petite SE; Hill MC
Ann Pharmacother; 2021 Nov; 55(11):1326-1332. PubMed ID: 33615832
[TBL] [Abstract][Full Text] [Related]
20. Insulin Glargine in Critically ill Patients: Once/Day versus Twice/Day Dosing.
Fox MA; Perry MC; Liu-DeRyke X
Pharmacotherapy; 2020 Mar; 40(3):186-190. PubMed ID: 31995840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
